Literature DB >> 25185078

Clinical characteristics, causes and outcomes of acute interstitial nephritis in the elderly.

Angela K Muriithi1, Nelson Leung1, Anthony M Valeri2, Lynn D Cornell3, Sanjeev Sethi3, Mary E Fidler3, Samih H Nasr3.   

Abstract

Acute interstitial nephritis (AIN) is an important cause of acute kidney injury (AKI), and its prevalence in the elderly may be increasing. It is largely unknown whether AIN in the elderly is similar to that in younger adults; therefore, we investigated the causes and characteristics of AIN in 45 elderly patients (65 years and older) and in 88 younger adults (18-64 years old). Compared with younger patients, the elderly had significantly more drug-induced AIN (87 vs. 64%), proton pump inhibitor-induced AIN (18 vs. 6%), but significantly less AIN due to autoimmune or systemic causes (7 vs. 27%). The two most common culprit drugs in the elderly were penicillin and omeprazole. Compared with younger patients, the elderly had higher prevalence of baseline CKD, higher peak creatinine, and more need for dialysis, all of which were significant. Among the elderly, 86% showed partial or complete recovery within 6 months. Significantly shorter delays in initiation of steroids correlated with recovery at 6 months. Lack of early recovery tended to correlate with progressive CKD. Compared with antibiotic-induced AIN, proton pump inhibitor-induced AIN had less severe AKI, but a longer duration of drug exposure, and was less likely to recover by 6 months, all significant. Thus, the vast majority of AIN cases in the elderly are due to drugs, primarily owing to proton pump inhibitors and antibiotics, while AIN of autoimmune or systemic origin is uncommon.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25185078     DOI: 10.1038/ki.2014.294

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  36 in total

Review 1.  Potential harms of proton pump inhibitor therapy: rare adverse effects of commonly used drugs.

Authors:  Amine Benmassaoud; Emily G McDonald; Todd C Lee
Journal:  CMAJ       Date:  2015-11-23       Impact factor: 8.262

2.  Duration of Treatment with Corticosteroids and Recovery of Kidney Function in Acute Interstitial Nephritis.

Authors:  Gema Fernandez-Juarez; Javier Villacorta Perez; Fernando Caravaca-Fontán; Luis Quintana; Amir Shabaka; Eva Rodriguez; Liliana Gadola; Alberto de Lorenzo; Maria Angeles Cobo; Aniana Oliet; Milagros Sierra; Carmen Cobelo; Elena Iglesias; Miguel Blasco; Cristina Galeano; Alfredo Cordon; Jesus Oliva; Manuel Praga
Journal:  Clin J Am Soc Nephrol       Date:  2018-11-05       Impact factor: 8.237

3.  Acute interstitial nephritis with membranous nephropathy in bucillamine-treated rheumatoid arthritis.

Authors:  Naoki Takamatsu; Hideki Takizawa; Hirohito Sugawara; Yayoi Ogawa
Journal:  CEN Case Rep       Date:  2015-12-08

4.  The use of anti-ulcer agents and the risk of chronic kidney disease: a meta-analysis.

Authors:  Jing Sun; Hongjun Sun; Meiyu Cui; Zhijian Sun; Wenyue Li; Jianxin Wei; Shuhua Zhou
Journal:  Int Urol Nephrol       Date:  2018-06-13       Impact factor: 2.370

5.  Proton Pump Inhibitors and CKD.

Authors:  Dennis G Moledina; Mark A Perazella
Journal:  J Am Soc Nephrol       Date:  2016-04-14       Impact factor: 10.121

Review 6.  Differentiating Acute Interstitial Nephritis from Acute Tubular Injury: A Challenge for Clinicians.

Authors:  Dennis G Moledina; Chirag R Parikh
Journal:  Nephron       Date:  2019-06-14       Impact factor: 2.847

Review 7.  Drug-Induced Acute Interstitial Nephritis.

Authors:  Dennis G Moledina; Mark A Perazella
Journal:  Clin J Am Soc Nephrol       Date:  2017-09-11       Impact factor: 8.237

8.  Phentermine induced acute interstitial nephritis.

Authors:  Emily Ximin Shao; Gregory John Wilson; Dwarakanathan Ranganathan
Journal:  BMJ Case Rep       Date:  2017-03-09

Review 9.  Drug-Induced Kidney Injury in the Elderly.

Authors:  Sana Khan; Valentina Loi; Mitchell H Rosner
Journal:  Drugs Aging       Date:  2017-10       Impact factor: 3.923

Review 10.  [Interstitial nephritis in rheumatic diseases].

Authors:  P Korsten; G A Müller
Journal:  Z Rheumatol       Date:  2015-05       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.